Progress in the research into minimal residual disease of childhood ALL and its applicationXIAO Yan, JIN Run-ming81-83
Different kinds of treatment for chronic myelogenous leukemia in children and the genetic evaluationXU Jia-wei, JIN Run-ming87-92
Significance of MICM typing in the diagnosis and treatment for acute leukemia in children and the prognosis evaluationSONG Ai-qin, SUN Li-rong92-94
Progress of the research into antibody targeting treatment for childhood leukemia and the prospect of its clinical applicationTANG Yong-min94-97
Elimination of minimal residual disease of leukemia in children with immunocompetent cell and the prospect of its clinical applicationMENG Pu, ZHOU Dong-feng97-99
Chemotherapy damage to the main organs of children with leukemia and its prevention and treatmentZHANG Zhi-quan, JIN Run-ming99-101
The comparisons of outcome and cost of three protocols for childhood non-high-risk acute lymphoblastic leukemia.罗学群, 官晓清, 林苑, 张映川, 黄礼彬, 张婷婷, 朱春浓, 刘全梁, 张晓莉, 柯志勇102-105
Vascular endothelial growth factor receptor 2 small hairpin RNA suppresses microvessel angiogenesis in leukemia mice.郭海霞, 陈纯, 麦友刚, 方建培106-108,插1
